---
title: "ENSC Q1'26 Earnings: EPS estimate is (0.73) USD"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/286552509.md"
description: "Ensysce Biosciences, Inc. (ENSC) will announce its Q1'26 earnings on May 18 at 8:00 AM ET. The revenue estimate is $1.90 million, with an anticipated EPS of $(0.73). Previous quarters showed varying revenue and EPS results, with notable surprises in EPS estimates. For more details, refer to the provided data."
datetime: "2026-05-15T11:00:05.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/286552509.md)
  - [en](https://longbridge.com/en/news/286552509.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/286552509.md)
---

# ENSC Q1'26 Earnings: EPS estimate is (0.73) USD

ENSC (Ensysce Biosciences, Inc.) is set to announce its Q1'26 results on May 18, time not specified. The earnings are expected to be disclosed at 8:00 AM ET (12:00 PM UTC).

For Q1'26, revenue estimate is 1.90 million USD with EPS (earnings per share) anticipated at (0.73) USD. Learn more details at .

**Revenue & EPS values are provided in USD**

Q1'25

Q2'25

Q3'25

Q4'25

Q1'26

**Revenue Reported**

1.31 M

—

493.10 K

1.90 M

—

**Revenue Estimate**

—

650.00 K

700.00 K

502.97 K

1.90 M

**Revenue Surprise**

\-29.56%

+277.76%

**EPS Reported**

(1.39)

(0.79)

(1.29)

(0.75)

**EPS Estimate**

(3.02)

(1.01)

(0.82)

(1.26)

(0.73)

**EPS Surprise**

+53.90%

+22.17%

\-56.36%

+40.48%

**Disclaimer**

Select reference data provided by FactSet. Copyright © 2026 FactSet Research Systems Inc.

### Related Stocks

- [ENSC.US](https://longbridge.com/en/quote/ENSC.US.md)
- [ARKG.US](https://longbridge.com/en/quote/ARKG.US.md)
- [XLV.US](https://longbridge.com/en/quote/XLV.US.md)
- [IXJ.US](https://longbridge.com/en/quote/IXJ.US.md)
- [XBI.US](https://longbridge.com/en/quote/XBI.US.md)
- [FBT.US](https://longbridge.com/en/quote/FBT.US.md)
- [PBE.US](https://longbridge.com/en/quote/PBE.US.md)
- [IHE.US](https://longbridge.com/en/quote/IHE.US.md)
- [SBIO.US](https://longbridge.com/en/quote/SBIO.US.md)
- [BIB.US](https://longbridge.com/en/quote/BIB.US.md)
- [BBH.US](https://longbridge.com/en/quote/BBH.US.md)
- [LABU.US](https://longbridge.com/en/quote/LABU.US.md)
- [IBB.US](https://longbridge.com/en/quote/IBB.US.md)
- [VHT.US](https://longbridge.com/en/quote/VHT.US.md)
- [ENSCW.US](https://longbridge.com/en/quote/ENSCW.US.md)

## Related News & Research

- [Ensysce Biosciences GAAP EPS of -$0.52 beats by $0.21](https://longbridge.com/en/news/286613093.md)
- [Eton Secures U.S. IMPAVIDO Rights; $4.25M Fees, Up To $4M Milestones And 50-55% Revenue Share](https://longbridge.com/en/news/286966420.md)
- [Full Transcript: Cellectar Biosciences Q1 2026 Earnings Call](https://longbridge.com/en/news/286422585.md)
- [Upsher-Smith launches Restasis generic cyclosporine ophthalmic emulsion 0.05%](https://longbridge.com/en/news/287079790.md)
- [Shah Capital Management Will Vote ‘No' Across Five Proposals On Novavax's June 18 Ballot - SEC Filing](https://longbridge.com/en/news/286565204.md)